Evidence map›Paper›PMID 41902842›Full record

ArticleBioinformatics (Oxford, England)2026

Enhancing mutation impact prediction in protein-protein interactions through interpretable graph-based multi-level feature interactions.

Shiwei Wu, Nan Xu, Xiaohui Xin, Min Zhang, Haoliang Liu, Hongjia Zhu, Zhenyu Wei, Chengkui Zhao, Lei Yu, Weixing Feng

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shiwei WuCollege of Intelligent Systems Science and Engineering, Harbin Engineering University, Harbin, China.ORCID 0009-0007-3392-521X
Nan XuInstitute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
Xiaohui XinCollege of Intelligent Systems Science and Engineering, Harbin Engineering University, Harbin, China.
Min ZhangCollege of Intelligent Systems Science and Engineering, Harbin Engineering University, Harbin, China.ORCID 0000-0001-9928-5189
Haoliang LiuCollege of Intelligent Systems Science and Engineering, Harbin Engineering University, Harbin, China.
Hongjia ZhuInstitute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
Zhenyu WeiCollege of Intelligent Systems Science and Engineering, Harbin Engineering University, Harbin, China.ORCID 0009-0001-2950-2560
Chengkui ZhaoCollege of Intelligent Systems Science and Engineering, Harbin Engineering University, Harbin, China.ORCID 0000-0002-4328-466X
Lei YuInstitute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
Weixing FengCollege of Intelligent Systems Science and Engineering, Harbin Engineering University, Harbin, China.ORCID 0000-0002-6466-7918

Funding

2023 Shanghai Municipal Science and Technology Innovation Action Plan Special Project on Cell and Gene Therapy 23J21901200Fundamental Research Funds for the Central Universities at Harbin Engineering University GK762026011560Fundamental Research Funds for the Central Universities at Harbin Engineering University GK762026011562National Natural Science Foundation of China 62172121National Natural Science Foundation of China 62572142
6 · The paper itself

Abstract

motivationProtein-protein interactions (PPIs) are central to cellular functions, and predicting mutation-induced changes in binding affinity (ΔΔG) remains challenging. Although existing computational methods integrate sequence- and structure-derived features and thus implicitly capture certain sequence-structure relationships, they typically fuse these modalities through simple concatenation, without explicitly modeling their multidimensional and multiscale interdependencies.

resultsHere, we introduce IGMI, an interpretable graph-based model that explicitly encodes multi-level feature interactions across 1D sequences, 2D contact maps, 3D structures, and residue- and atom-level representations. By recalibrating cross-dimensional and cross-scale dependencies, IGMI enables more accurate estimation of both local and long-range mutation effects. Across multiple benchmark datasets, IGMI consistently outperforms state-of-the-art methods in accuracy, robustness, and interpretability. Macro- and micro-level analyses further reveal biologically plausible patterns, distinguishing direct interface perturbations from indirect structural reorganizations. Complementary analyses under different data splitting strategies indicate that the model learns generalizable affinity-related interaction patterns, rather than relying on split-specific information. IGMI provides a reliable and interpretable framework for modeling mutation-induced affinity changes, supporting applications in protein engineering and therapeutic design. AVAILABILITY AND IMPLEMENTATION: IGMI is implemented in PyTorch and released under an open-source license. The full codebase, training scripts, and evaluation utilities are available at https://github.com/ShiweiWu-545/IGMI.git. An archival snapshot containing all source code, pre-trained weights, processed datasets, and reproducibility scripts is available on Zenodo (https://doi.org/10.5281/zenodo.17563574). CONTACT: fengweixing@hrbeu.edu.cn; yulei@nbic.ecnu.edu.cn; zhaochengkui@hrbeu.edu.cn. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Computational BiologyMutationProtein Interaction MappingProteinsAlgorithmsDatabases, ProteinProtein BindingProteins

Identifiers

PMID41902842
PMCPMC13070472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.